Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

CoreAge Rx vs Apex MD

Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Apex MD a 75. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

CoreAge Rx

#1 · Grade A+ · Best Value

Est. first month

$99/mo

Save ~89% vs brand-name
Get this deal Full CoreAge Rx review →
VS

Apex MD

#131 · Grade C+ · Fair Price

Est. first month

$299/mo

Save ~78% vs brand-name
Get this deal Full Apex MD review →

The verdict

Better value: CoreAge Rx

CoreAge Rx takes it on Value Score, 93 to 75 an est. $99/mo first month, with no teaser step-up baked in. Apex MD isn't out of it: Someone who specifically wants a blended formulation rather than the molecule on its own.

CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealCoreAge RxApex MD
Value Score93 (A+)75 (C+)
Est. first month$99/mo$299/mo
Save vs brand-name~89%~78%
Semaglutide$99/mo$299/mo
Tirzepatide$149/mo$399/mo
Both moleculesYesYes
PricingFlat — no step-upFlat — no step-up
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

88
Lowest Real Price
58
CoreAge Rx: 88. Apex MD: 58.
98
No Teaser-Rate Bait
90
CoreAge Rx: 98. Apex MD: 90.
98
Nationwide Availability
96
CoreAge Rx: 98. Apex MD: 96.
95
Both Molecules
98
CoreAge Rx: 95. Apex MD: 98.
95
Easy Cancellation
58
CoreAge Rx: 95. Apex MD: 58.
84
Reputation
69
CoreAge Rx: 84. Apex MD: 69.

CoreAge Rx

The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.

Why it's a deal

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation — no lock-in

The fine print

  • Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

Apex MD

Apex MD is a virtual practice licensed in all 50 states, prescribing compounded GLP-1s blended with NAD+, B-12 and L-carnitine at $299 for semaglutide and $399 for tirzepatide.

Why it's a deal

  • The rate holds at every dose on both molecules, so titrating up does not raise the bill
  • Licensed in all 50 states, with an oral route as well as injections
  • One of the larger operations tracked here by its own count, citing more than 300,000 people helped
  • States its blend openly on the product rather than describing it only as "semaglutide"

The fine print

  • The compound bundles NAD+, B-12 and L-carnitine rather than being single-ingredient, so it is not directly comparable with a plain semaglutide price
  • $299 sits well above the roughly $179 semaglutide median across the programs tracked here
  • Apex does not name its compounding pharmacy or display an accreditation seal
  • The 97% satisfaction figure is the company's own, with no published methodology
Get the CoreAge Rx deal Get the Apex MD deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Apex MD.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.